Anti-viral therapy using lamivudine and thymosin is helpful to prevent recurrence in hepatocellular carcinoma with coexisting active hepatitis B

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 27, Issue 2, 2005, Pages 114-116

  Cheng, Shu qun ^a   Wu, Meng chao ^a   Chen, Han ^a   Shen, Feng ^a   Yang, Jia he ^a   Cong, Wen ming ^a   Zhao, Yu xiang ^a   Wang, Pei jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THYMOSIN; THYMOSIN ALPHA1; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENETICS; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TUMOR RECURRENCE; VIROLOGY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; HEPATECTOMY; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; REVERSE TRANSCRIPTASE INHIBITORS; SURVIVAL RATE; THYMOSIN;

EID: 26944489297     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)